• Labeyond Yellow Powder Iron Succinate C4h4feo4 CAS 10030-90-7
  • Labeyond Yellow Powder Iron Succinate C4h4feo4 CAS 10030-90-7
  • Labeyond Yellow Powder Iron Succinate C4h4feo4 CAS 10030-90-7
  • Labeyond Yellow Powder Iron Succinate C4h4feo4 CAS 10030-90-7
  • Labeyond Yellow Powder Iron Succinate C4h4feo4 CAS 10030-90-7
  • Labeyond Yellow Powder Iron Succinate C4h4feo4 CAS 10030-90-7

Labeyond Yellow Powder Iron Succinate C4h4feo4 CAS 10030-90-7

CAS No.: 10030-90-7
Formula: C4h4feo4
EINECS: 233-082-3
Classification: High Purity Material
Grade: CP
Specific Usage: Cosmetic Grade
Samples:
US$ 10/kg 1 kg(Min.Order)
| Request Sample
Customization:
Diamond Member Since 2023

Suppliers with verified business licenses

Rating: 5.0/5
Manufacturer/Factory
  • Overview
  • Product Description
Overview

Basic Info.

Model NO.
10030-90-7
Usage
Medicial Process
Source
Dry Powder
Habit Appellation
Chemical Medicine
Application
Health
Property
Biochemical Reagent
Sample
Available
Self-Life
2 Years
MOQ
1kg
Storage
Cool Dry Place
Other Name
Montmorillonite Ksf
Transport Package
Bag
Specification
Beeswax
Trademark
Labeyond
Origin
China
Production Capacity
500mt/Month

Product Description

 
Product Description
CAS
10030-90-7
MF
C4H4FeO4
Sample
Availiable
Appearance
Powder
Shelf life
24 Months
Storage
Cool Dry Place
Purity
99%
Molecular Weight
171.91700
 
Labeyond Yellow Powder Iron Succinate C4h4feo4 CAS 10030-90-7
Labeyond Yellow Powder Iron Succinate C4h4feo4 CAS 10030-90-7




Application: Ferrous succinate can be used for the prevention and treatment of iron deficiency anemia.

Adverse reactions 1. Visible gastrointestinal adverse reactions, such as nausea, vomiting, upper abdominal pain, and constipation. 2. Ferrous succinate can reduce intestinal peristalsis, cause constip

Pharmacological effects,:iron is a component of hemoglobin in red blood cells. When iron deficiency occurs, red blood cells produce less hemoglobin, which reduces the size of the red blood cells

Notes :1. Hepatic and renal function is severely impaired, especially in patients with untreated urinary tract infection. 2. Not used in patients with iron overload, hemochromatosis, or hemosiderosis. 3. Non iron deficiency anemia (such as thalassemia) patients are prohibited.



Best Quality Product: we own professional quality management and process inspection team.
Best Deal:The quality of goods that you can buy can be guaranteed.
Quick Delivery: A strong logistics system can selver goods all parts of world.

Labeyond Yellow Powder Iron Succinate C4h4feo4 CAS 10030-90-7Labeyond Yellow Powder Iron Succinate C4h4feo4 CAS 10030-90-7Labeyond Yellow Powder Iron Succinate C4h4feo4 CAS 10030-90-7Labeyond Yellow Powder Iron Succinate C4h4feo4 CAS 10030-90-7Labeyond Yellow Powder Iron Succinate C4h4feo4 CAS 10030-90-7Labeyond Yellow Powder Iron Succinate C4h4feo4 CAS 10030-90-7Labeyond Yellow Powder Iron Succinate C4h4feo4 CAS 10030-90-7

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now